Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05107752 · ClinicalTrials.gov registry record · Phase 2
Stellate Ganglion Block to Augment Trauma-focused Therapy Among Veterans With PTSD
A Phase 2 study, sponsored by Ohio State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 85
- Enrollment target
NCT05107752 is a Phase 2 study that has completed, run by Ohio State University. The registered enrollment target is 85 participants.
The verdict
NCT05107752, a Phase 2 study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 85 participants
- Enrollment target
Study Summary
Our long-term goal is to improve clinical outcomes among patients receiving psychological treatment for posttraumatic stress disorder (PTSD). The primary objective of this project is to examine if stellate ganglion block (SGB) improves outcomes among military personnel and veterans receiving cognitive processing therapy (CPT), an empirically-supported psychological treatment for PTSD. To accomplish this objective, we will enroll adult military personnel and veterans with a current diagnosis of PTSD and/or subthreshold PTSD, provide CPT sessions over two weeks, administer SGB during or after CPT, and repeatedly assess key outcomes during follow-up.
Interventions
- BEHAVIORAL Cognitive Processing Therapy (CPT)
- DRUG Stellate Ganglion Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2022-01-03 |
| Est. Completion | 2025-03-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05107752
The ClinicalTrials.gov registry entry for NCT05107752 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cognitive Processing Therapy (CPT) is the first listed.
NCT05107752 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05107752 about?
NCT05107752 is a clinical study titled "Stellate Ganglion Block to Augment Trauma-focused Therapy Among Veterans With PTSD". Our long-term goal is to improve clinical outcomes among patients receiving psychological treatment for posttraumatic stress disorder (PTSD). The primary objective of this project is to examine if stellate ganglion block (SGB) improves outcomes among military personnel and veterans receiving cogniti...
What is the current status of trial NCT05107752?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 85 participants. The study started on 2022-01-03. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT05107752?
The interventions under investigation include: Cognitive Processing Therapy (CPT) (BEHAVIORAL), Stellate Ganglion Block (DRUG).
Who is sponsoring clinical trial NCT05107752?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.